TYME Announces Third Quarter Fiscal 2020 Financial and Operating Results
Strategic collaboration with Eagle Pharmaceuticals entitles TYME to receive up to a total of $40 million, which included $20 million […]
Atossa Therapeutics, Inc. to Present at the 22nd Annual BIO CEO & Investor Conference
SEATTLE, Feb. 05, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery […]
TSX News -
WSP Announces Fourth Quarter and Fiscal 2019 Results Release Date
MONTREAL, Feb. 05, 2020 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) will announce its 2019 […]
TSX News -
Patriot One’s Xtract.ai Division Secures $975,000 Contract for Department of National Defense
VANCOUVER, British Columbia, Feb. 05, 2020 (GLOBE NEWSWIRE) — Xtract Technologies Inc. (“Xtract.ai”), a subsidiary of Patriot One Technologies Inc. […]
WeedMD Wins Award for London’s Best Places to Work 2020
TORONTO, Feb. 05, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]
Siyata Mobile Receives $600,000 Purchase Order for 4G Rugged Push-To-Talk Handsets
MONTREAL, Feb. 05, 2020 (GLOBE NEWSWIRE) — Siyata Mobile Inc. (TSX-V:SIM | OTCQX: SYATF) (the “Company” or “Siyata”) is pleased […]
Kutcho Copper Provides Corporate Update
VANCOUVER, British Columbia, Feb. 05, 2020 (GLOBE NEWSWIRE) — Kutcho Copper Corp. (TSXV: KC) (OTC: KCCFF) (“Kutcho Copper” or the […]
Stryker declares a $0.575 per share quarterly dividend
Kalamazoo, Michigan, Feb. 05, 2020 (GLOBE NEWSWIRE) — Kalamazoo, Michigan – February 5, 2020 – Stryker (NYSE:SYK) announced that its […]
Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2019 Results on March 4, 2020
NEW ALBANY, Ohio, Feb. 05, 2020 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will be holding its quarterly […]
Oncocyte Closes Merger Agreement to Acquire Insight Genetics
Acquisition broadens suite of molecular diagnostic tests to include potentially transformative immunotherapy response prediction test demonstrated to outperform PD-L1 and […]
